Science Highlights 2023: Gastrointestinal Cancer

This session highlights the most clinically relevant abstracts within the Gastrointestinal Cancer track of the 2023 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field. The Discussant compares and contrasts the current data to help you digest the latest science; places the study into context; and describes how the study can be put into clinical practice, if recommended. 
 
Highlighted abstracts include:

  • Electrocardiogram with artificial intelligence assessment as a predictor of cardiac events and overall survival in patients receiving radiotherapy for esophageal cance
  • Phase 1 Trial of SPECT-Guided Liver-Directed Radiotherapy  for Patients with Low Functional Liver Volume
  • Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma: A Randomized Phase 2 Clinical Trial  
  • Risks of Erectile Dysfunction, Ejaculatory Dysfunction, and Testosterone Deficiency in Men Treated with Pelvic RT for Locally Advanced Rectal Cancer
  • Long-Term Anorectal Function in Rectal Cancer Patients Managed by a Watch-and-Wait Strategy after Neoadjuvant Therapy: A Cross-Sectional Study
  • Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED): Assessment of Pathologic Response in a Prospective, Phase II Single-Arm Trial

This activity is available from March 26, 2024, through 11:59 p.m. Eastern time on December 31, 2024. 

This activity was originally recorded at the 2023 ASTRO Annual Meeting in San Diego, California.

Target Audience

The activity is designed to meet the interests of radiation oncologists, radiation oncology residents, physicists and radiation dosimetrists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Gain knowledge of the use and technique of radiation therapy for gastrointestinal cancers.
  • Compare and contrast current data in gastrointestinal cancer.
Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 0.50 Certificate of Attendance
    This activity was designated for 0.50 AMA PRA Category 1 Credit™.
Course opens: 
03/26/2024
Course expires: 
12/31/2024
Cost:
$79.00
Rating: 
0

Discussant: Dan Chang, MD

Dan Chang is employed by the University of Michigan and received honoraria and travel compensation from Varian.

The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.

Disclosure link: 
Committee Disclosures

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 0.50 Certificate of Attendance
    This activity was designated for 0.50 AMA PRA Category 1 Credit™.

Price

Cost:
$79.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the free member rate.

Nonmember: $79
Member: Free 

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the ASTRO website until December 31, 2024, regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.